Reporting owner · CIK 0001698082
Shah Nimish P
Visual SEC Form 4 history across 3 companies, 14 transactions and 5 filings.
DIRKorsana Biosciences, Inc.
Open-market mix
100%buys
Open-market buy performance
90-day forward return on this insider's open-market purchases
Forward return is not available yet
We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for some of their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.
Monthly open-market activity
Reported purchase and sale transaction counts
Buys Sells
Net value flow
Buys minus sells
Jan 25
$487.4K
Feb 25
$4M
Sep 26
$0
Transaction texture
Ownership and ticket size
Average P/S size$345.8K
Median P/S size$173.9K
Direct1
Indirect13
Sep 09, 2026grant
Filing-only signals
Deterministic matches in this insider's history
Latest Form 4 facts
Quick context from source filings
Latest transaction
buy at Oruka Therapeutics, Inc. on Feb 14, 2025 valued at $1,015,803.
Review SEC filingLatest sale
No open-market insider sale is available.
| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| KALV | Shah Nimish P | 10% | buy | 73.6k | $68.4M | P | — | 02/12/2025 | 02/07/2025 | |
| KALV | Shah Nimish P | 10% | buy | 14.5k | $13.4M | P | — | 02/04/2025 | 02/03/2025 | |
| KALV | Shah Nimish P | 10% | buy | 11.7k | $10.4M | P | — | 02/04/2025 | 01/31/2025 | |
| KALV | Shah Nimish P | 10% | buy | 43.7k | $38.2M | P | — | 02/04/2025 | 01/30/2025 |
Shah Nimish P Insider Activity FAQ
SEC Form 4 context
Who is Shah Nimish P?
Shah Nimish P is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001698082.
Which companies has Shah Nimish P reported transactions for?
Korsana Biosciences, Inc., Oruka Therapeutics, Inc., KalVista Pharmaceuticals, Inc.
When was Shah Nimish P's latest insider buy?
buy at Oruka Therapeutics, Inc. on Feb 14, 2025 valued at $1,015,803.
When was Shah Nimish P's latest insider sale?
No open-market insider sale is available for this period.
Where can I see the original SEC filings?
Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.
Are performance metrics included?
This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.